Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
CytoMed Therapeutics Limited (NASDAQ : GDTC) Stock
MWN-AI** Summary
MWN-AI** Analysis
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Description
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies into creating novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors.
Quote
| Last: | $1.11 |
|---|---|
| Change Percent: | 0.0% |
| Open: | $1.16 |
| Close: | $1.11 |
| High: | $1.18 |
| Low: | $1.1012 |
| Volume: | 1,926 |
| Last Trade Date Time: | 06/05/2026 11:15:39 am |
Stock Data
| Market Cap: | $12,347,800 |
|---|---|
| Float: | 3,280,822 |
| Insiders Ownership: | N/A |
| Institutions: | 5 |
| Short Percent: | N/A |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | https://www.cytomed.sg |
| Country: | SG |
| City: | Singapore |
Recent News Releases
Subscribe to Our Newsletter
**MWN-AI FAQ is based on asking OpenAI questions about CytoMed Therapeutics Limited (NASDAQ: GDTC).
